CELLSCRIPT
Biotechnology ResearchWisconsin, United States11-50 Employees
CELLSCRIPT™ provides products and technologies for making and using RNA for translation in cells for clinical research and therapeutics, including RNA comprising pseudouridine (Ψ) and other modified nucleosides covered by patents licensed from the University of Pennsylvania. Products include enzymes and kits for in vitro transcription, co-transcriptional or post-transcriptional 5’ RNA capping, and 3’ RNA polyadenylation.